The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
Open accessAbstract
The coumarin (benzopyran-2-one, or chromen-2-one) ring system, present in natural products (such as the anticoagulant warfarin) that display interesting pharmacological properties, has intrigued chemists and medicinal chemists for decades to explore the natural coumarins or synthetic analogs for their applicability as drugs. Many molecules based on the coumarin ring system have been synthesized utilizing innovative synthetic techniques. The diversity oriented synthetic routes have led to interesting derivatives including the furanocoumarins, pyranocoumarins, and coumarin sulfamates (COUMATES), which have been found to be useful in photochemotherapy, antitumor and anti-HIV therapy, and as stimulants for central nervous system, antibacterials, anti-inflammatory, anti-coagulants, and dyes. Of particular interest in breast cancer chemotherapy, some coumarins and their active metabolite 7-hydroxycoumarin analogs have shown sulfatase and aromatase inhibitory activities. Coumarin based selective estrogen receptor modulators (SERMs) and coumarin-estrogen conjugates have also been described as potential antibreast cancer agents. Since breast cancer is the second leading cause of death in American women behind lung cancer, there is a strong impetus to identify potential new drug treatments for breast cancer. Therefore, the objective of this review is to focus on important coumarin analogs with antibreast cancer activities, highlight their mechanisms of action and structure-activity relationships on selected receptors in breast tissues, and the different methods that have been applied in the construction of these pharmacologically important coumarin analogs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive Heterocyclic Chemistry II
KATRITZKY, A. R., Rees, C. W., & Scriven, E. F. V. (1997) · Medical Entomology and Zoology · Cited by 8,499
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
Esters of Methanesulfonic Acid as Irreversible Inhibitors of Acetylcholinesterase
Kitz, R., & Wilson, I. B. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50153-8 · Cited by 1,519
Simple Coumarins and Analogues in Medicinal Chemistry: Occurrence, Synthesis and Biological Activity
Borges, F., Roleira, F., Milhazes, N., Santana, L., & Uriarte, E. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053507315 · Cited by 994
Natural and Synthetic Coumarin Derivatives with Anti-Inflammatory / Antioxidant Activities
Fylaktakidou, K., Hadjipavlou-Litina, D., Litinas, K., & Nicolaides, D. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382710 · Cited by 970
Hoult, J. R. S., & Payá, M. (1996) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(95)02112-4 · Cited by 951
The natural coumarins : occurrence, chemistry, and biochemistry
Murray, R. D., Méndez, J., & Brown, S. A. (1982) · Andalas University Repository (Andalas University) · Cited by 793
Eiermann, W., Paepke, S., Appfelstaedt, J., Llombart-Cussac, A., Eremin, J., Vinholes, J., Mauriac, L., Ellis, M., Lassus, M., Chaudri-Ross, H. A., et al. (2001) · Annals of Oncology · doi:10.1023/a:1013128213451 · Cited by 713
Multistage carcinogenesis in mouse skin
DiGiovanni, J. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90051-z · Cited by 642
Lacy, A. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382693 · Cited by 635
Cited by
Benign by design: catalyst-free in-water, on-water green chemical methodologies in organic synthesis
Gawande, M. B., Bonifácio, V. D. B., Luque, R., Branco, P. S., & Varma, R. S. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60025d · Cited by 674
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer
Küpeli Akkol, E., Genç, Y., Karpuz, B., Sobarzo-Sánchez, E., & Capasso, R. (2020) · Cancers · doi:10.3390/cancers12071959 · Cited by 493
Coumarin heterocyclic derivatives: chemical synthesis and biological activity
Medina, F. G., Marrero, J. G., Macías-Alonso, M., González, M. C., Córdova-Guerrero, I., Teissier García, A. G., & Osegueda-Robles, S. (2015) · Natural Product Reports · doi:10.1039/c4np00162a · Cited by 469
Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
Riveiro, M., De Kimpe, N., Moglioni, A., Vazquez, R., Monczor, F., Shayo, C., & Davio, C. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790936284 · Cited by 448
Nepali, K., Sharma, S., Sharma, M., Bedi, P. M. S., & Dhar, K. L. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.018 · Cited by 435
Xu, W., Jiao, L., Yan, H., Wu, Y., Chen, L., Gu, W., Du, D., Lin, Y., & Zhu, C. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b03004 · Cited by 395
Li, J., Sui, Y.-P., Xin, J.-J., Du, X.-L., Li, J.-T., Huo, H.-R., Ma, H., Wang, W.-H., Zhou, H.-Y., Zhan, H.-D., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.10.063 · Cited by 326
The Structure and Pharmacological Functions of Coumarins and Their Derivatives
Wu, L., Wang, X., Xu, W., Farzaneh, F., & Xu, R. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789578187 · Cited by 289
Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents
Keri, R. S., B.S., S., Nagaraja, B. M., & Santos, M. A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.06.017 · Cited by 271
Role of dietary bioactive natural products in estrogen receptor-positive breast cancer
Bak, M. J., Das Gupta, S., Wahler, J., & Suh, N. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.03.001 · Cited by 80
Kim, C. Y., Mitchell, A. J., Kastner, D. W., Albright, C. E., Gutierrez, M. A., Glinkerman, C. M., Kulik, H. J., & Weng, J.-K. (2023) · Nature Communications · doi:10.1038/s41467-023-36299-1 · Cited by 25
Metadata
- Authors
- Musa, M., Cooperwood, J., & Khan, M. O.
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2008-11-01
- Volume
- 15
- Issue
- 26
- Pages
- 2664-2679
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2148738581
- Cited by
- 538
- References
- 103
- FWCI
- 5.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.